Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis 2021-06-01 16:00
1